Published on:

Transvaginal Mesh Update Regarding C.R. Bard & Johnson & Johnson

Transvaginal Mesh Update

 

As summer ends there is optimism regarding upcoming transvaginal mesh settlements. Recently firms have settled with C.R. Bard, and Coloplast for sums that exceed the previous settlements with American Medical Systems, (AMS).

 

Recently C.R. Bard settled approximately 3,000 cases for 200 million dollars. This number exceeds the previous per case average set by the American Medical Systems settlement from May of 2014. C.R. Bard manufactured Avaulta mesh for pelvic organ prolapse, and several other products for stress urinary incontinence, such as the Align, and the Ajust. The Naumes Law Group is optimistic that settlements for women who have been injured by products manufactured by Boston Scientific and Ethicon will occur in the near future.

 

In July of 2015, Judge Goodwin who presides over the MDL’s of the Southern District of West Virginia consolidated 39 cases of women who were implanted with the Ethicon TVT for a trial on design defect. Previous consolidated trials against Boston Scientific have resulted in significant jury verdicts for women who were implanted with defective Boston Scientific mesh, in both West Virginia and Florida.

 

The Johnson & Johnson consolidated trial is scheduled to begin on December 4, 2015. Let the Naumes Law Group evaluate your potential vaginal mesh case. If you have been implanted with transvaginal mesh please call our firm to discuss your options.

 

If you have been implanted with transvaginal mesh and have experienced mesh erosion, urinary tract infections, revision surgery, or any other treatment, please contact us to discuss a potential case.